Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-17299425 in traumatic brain injury with elevated intracranial pressure
2007-000280-17Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of JNJ-17299425 in traumatic brain injury (TBI), sponsored by Janssen Pharmaceutical. Primary endpoint: Reduction in intracranial pressure. Started Apr 2007; status: completed.
02
Drugs
JNJ-17299425
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2007-000280-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000280-17.